Physician profile
Beki E Garrett
NPI 1629231808
$1,727.44
in general payments reported to CMS, 2019-2025
14 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $256 · 2023: $253 · 2024: $494 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.52 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $561.42 | 2021-2025 | Dupixent |
| Optinose US, INC. | $472.37 | 2021-2025 | |
| Genzyme Corporation | $159.15 | 2023-2025 | |
| Kaleo, INC. | $113.08 | 2021-2023 | Auvi-Q |
| Glaxosmithkline, LLC. | $80.54 | 2023-2025 | Nucala |
| Amgen INC. | $70.61 | 2025 | Tezspire |
| Aerin Medical INC. | $65.42 | 2021-2025 | |
| Itamar Medical INC | $54.97 | 2024 | Watchpatone |
| Stryker Corporation | $38.00 | 2021 | |
| Abbvie INC. | $32.10 | 2021-2022 | |
| Acclarent, INC | $28.56 | 2021-2023 | Relieva Tract |
| Allergan, INC. | $20.72 | 2022 | |
| Hikma Pharmaceuticals USA | $16.83 | 2024 | Ryaltris |
| Ars Pharmaceuticals Operations, INC. | $13.67 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beki Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.